FocaL Mass Drug Administration for Vivax Malaria Elimination | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
FocaL Mass Drug Administration for Vivax Malaria Elimination	Infections, Mosquito-Borne Diseases, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease	Recruiting	Phase 3	2026-06-09		NCT05690841

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
GlaxoSmithKline	294
Medicines for Malaria Venture	5
Menzies School of Health Research	15
National Institute of Allergy and Infectious Diseases (NIAID)	402
Oxford University Clinical Research Unit Indonesia	6
PATH	16
Stanford University	620
Universidad Peruana Cayetano Heredia	12
University of California, San Francisco	637

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Asociación Civil Selva Amazónica	Iquitos	Peru	1